APA

Ruth M. M., Sangen J. J. N., Remmers K., Pennings L. J., Svensson E., Aarnoutse R. E., Zweijpfenning S. M. H., Hoefsloot W., Kuipers S., Magis-Escurra C., Wertheim H. F. L. & van Ingen J. (20200630). A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. : The Journal of antimicrobial chemotherapy.

Chicago

Ruth Mike Marvin, Sangen Jasper J N, Remmers Karlijn, Pennings Lian J, Svensson Elin, Aarnoutse Rob E, Zweijpfenning Sanne M H, Hoefsloot Wouter, Kuipers Saskia, Magis-Escurra Cecile, Wertheim Heiman F L and van Ingen Jakko. 20200630. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. : The Journal of antimicrobial chemotherapy.

Harvard

Ruth M. M., Sangen J. J. N., Remmers K., Pennings L. J., Svensson E., Aarnoutse R. E., Zweijpfenning S. M. H., Hoefsloot W., Kuipers S., Magis-Escurra C., Wertheim H. F. L. and van Ingen J. (20200630). A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. : The Journal of antimicrobial chemotherapy.

MLA

Ruth Mike Marvin, Sangen Jasper J N, Remmers Karlijn, Pennings Lian J, Svensson Elin, Aarnoutse Rob E, Zweijpfenning Sanne M H, Hoefsloot Wouter, Kuipers Saskia, Magis-Escurra Cecile, Wertheim Heiman F L and van Ingen Jakko. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. : The Journal of antimicrobial chemotherapy. 20200630.